Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.

Frontiers in medicine(2023)

引用 0|浏览13
暂无评分
摘要
https://beta.clinicaltrials.gov/study/NCT04625738, identifier NCT04625738.
更多
查看译文
关键词
ARDS, COVID-19, mesenchymal stromal cells, intensive care, oxygenation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要